EDGAR Filing Documents for 0001393905-18-000012

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

SEC Accession No. 0001393905-18-000012

Filing Date

2018-01-11

Accepted

2018-01-11 11:06:46

Documents

Period of Report

2018-01-03

Document Format Files

Seq	Description	Document	Type	Size
1	PRIMARY DOCUMENT	primary_doc.html	4/A
1	PRIMARY DOCUMENT	primary_doc.xml	4/A	3838
	Complete submission text file	0001393905-18-000012.txt		5675

Mailing Address 47 AVENUE ROAD SUITE 200 TORONTO A6 M5R 2G3

Business Address 47 AVENUE ROAD SUITE 200 TORONTO A6 M5R 2G3 416-929-1806

PORTAGE BIOTECH INC. (Reporting) CIK: 0001095435 (see all company filings)

State of Incorp.: A6 | Fiscal Year End: 0331
Type: 4/A | Act: 34 | File No.: 001-38080 | Film No.: 18523012
SIC: 1311 Crude Petroleum & Natural Gas
Office of Energy & Transportation

Mailing Address 234 CHURCH STREET, SUITE 304 NEW HAVEN CT 06510

Business Address 234 CHURCH STREET, SUITE 304 NEW HAVEN CT 06510 203-404-0410

Biohaven Pharmaceutical Holding Co Ltd. (Issuer) CIK: 0001689813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences